Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Read Article
News
2024
2023
Archive
Search news articles
August 11, 2022
Homology Medicines Announces Optimized, In Vivo Gene Therapy Candidate for the Treatment of Metachromatic Leukodystrophy
August 11, 2022
Nouscom Announces Leading Publication Revealing an Immune Mechanism of Action Driving Anti-Tumor Activity of Adenovirus Vectored Vaccines and Anti-PD1 Immunotherapy
August 10, 2022
Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst®
August 9, 2022
CCRM Fertility and TMRW Life Sciences to Expand Partnership Modernizing IVF Specimen Management Across All Locations
August 8, 2022
Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
August 8, 2022
CinCor Pharma Announces Positive Topline Data for Phase 2 BrigHtn Trial Evaluating Baxdrostat, its Selective Aldosterone Synthase Inhibitor, in Treatment-Resistant Hypertension
August 3, 2022
Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder
August 3, 2022
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
August 3, 2022
Pear Therapeutics to be Added to Russell US Index Series
August 2, 2022
Arvinas Appoints John Northcott as Chief Commercial Officer
« Previous Page
1
…
8
9
10
11
12
…
17
Next Page »